287 related articles for article (PubMed ID: 19782305)
1. Omega-3 lipids for intestinal failure associated liver disease.
Diamond IR; Pencharz PB; Wales PW
Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
[TBL] [Abstract][Full Text] [Related]
2. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
Venick RS; Calkins K
Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
[TBL] [Abstract][Full Text] [Related]
3. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
[TBL] [Abstract][Full Text] [Related]
4. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
5. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
6. Failure of resolution of portal fibrosis during omega-3 fatty acid lipid emulsion therapy in two patients with irreversible intestinal failure.
Soden JS; Lovell MA; Brown K; Partrick DA; Sokol RJ
J Pediatr; 2010 Feb; 156(2):327-31. PubMed ID: 20105644
[TBL] [Abstract][Full Text] [Related]
7. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
Carter BA; Karpen SJ
Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
[TBL] [Abstract][Full Text] [Related]
8. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
Nasr A; Diamond IR; de Silva NT; Wales PW
J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
[TBL] [Abstract][Full Text] [Related]
9. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
10. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
11. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis.
Diamond IR; de Silva NT; Tomlinson GA; Pencharz PB; Feldman BM; Moore AM; Ling SC; Wales PW
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5):596-602. PubMed ID: 21825088
[TBL] [Abstract][Full Text] [Related]
12. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
13. Expert beliefs regarding novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
Diamond IR; Grant RC; Feldman BM; Tomlinson GA; Pencharz PB; Ling SC; Moore AM; Wales PW
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):702-10. PubMed ID: 23917524
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the management of intestinal failure-associated liver disease.
Wiles A; Woodward JM
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
[TBL] [Abstract][Full Text] [Related]
15. A detailed guide to lipid therapy in intestinal failure.
Gura KM; Crowley M
Semin Pediatr Surg; 2018 Aug; 27(4):242-255. PubMed ID: 30342599
[TBL] [Abstract][Full Text] [Related]
16. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Cheung HM; Lam HS; Tam YH; Lee KH; Ng PC
Clin Nutr; 2009 Apr; 28(2):209-12. PubMed ID: 19261360
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease.
Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Dao DT; Fell GL; Gura KM; Puder M
JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):71-77. PubMed ID: 29505154
[TBL] [Abstract][Full Text] [Related]
18. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.
Koletzko B; Goulet O
Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):321-6. PubMed ID: 20393276
[TBL] [Abstract][Full Text] [Related]
19. Parenteral ω-3 fatty acid lipid emulsions for children with intestinal failure and other conditions: a systematic review.
Seida JC; Mager DR; Hartling L; Vandermeer B; Turner JM
JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):44-55. PubMed ID: 22683686
[TBL] [Abstract][Full Text] [Related]
20. Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion.
Le HD; Gura KM; Arsenault DA; Fallon EM; Potemkin AK; Puder M
J Pediatr; 2010 Sep; 157(3):517; author reply 518. PubMed ID: 20584532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
